European Commission thinking on SPCs under the UPC, Off-patent Drugs Bill failing again in UK, the TPP being published, a WTO TRIPS Council’s decision on a pharma protection exemption request by LDCs, the European Parliament endorsing a plan to increase the number of General Court judges, and a Law Society report on Brexit and IP were in the recent IP headlines in Europe
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
As specialist boutiques challenge traditional firm models, major disputes involving Disney, Ericsson, Siemens and Dolby highlight the firms winning work before the UPC
Josh Seidenfeld, partner at DLA Piper, outlines the emerging legal trends that drive the future of life sciences innovation and how stakeholders can prepare for the future
South Korea's One Law Partners is combining with boutique firm Minwho Law Group to leverage global expansion of K-content and build a broader offering spanning IP, tech and regulatory advisory work
Attorney Oran Friar and trainee attorney Harry Cunliffe at Reddie & Grose, share that patent filings for clinical LLMs are surging, but success in the UK and Europe hinges on demonstrating technical innovation
The first credible UPC spinouts are growing, and they are coming from elite patent litigation teams, suggesting specialist litigators may no longer need large platforms to compete